Degarelix Proves to be the Superior Hormone Deprivation Treatment (ADT) for Men with Advanced Prostate Cancer
Based on six recent retrospective analyses comparing the gonadotropin-releasing hormone (GnRH) antagonist degarelix against the traditional luteinizing hormone-releasing hormone (LHRH) agonists (i.e. Zoladex, Lupron etc.) men with advanced prostate cancer experienced improved disease control, fewer [...]
Bone Disease in Men with Prostate Cancer Needs Constant Monitoring
The number of cancer survivors is increasing, soon to be as many of 13 million of us in the world! Bones are often affected in cancer survivors, usually a result of bone metastases, or of [...]
Caregiving -It Isn’t Easy
Becoming a full time 24/7 caregiver for someone with any chronic illness, including advanced prostate cancer is overwhelming. Most caregivers find that they stop their own personal activities, including those that give them personal pleasure. [...]
Why Xofigo is Superior to Other Radiopharmaceuticals for Advanced Prostate Cancer Treatment
We are in the fortunate position because the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) continues to evolve as new agents with the ability to extend survival gain FDA approval. The most recently [...]
Positive Surgical Margins – Do They Really Matter and Do They Effect How Long You Are Going To Live?
Men who elect to have a radical prostatectomy (surgical treatment for prostate cancer) as their primary treatment often panic if they find out that they had positive surgical margins (PSMs). Positive surgical margins are an [...]
Is Zytiga with Prednisone Effective in Men with Metastatic Prostate Cancer Who Have Visceral Disease?
Castate resistant metastatic prostate cancer (mRPC) withvisceral disease (tumors involving the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas or intestines) is [...]